Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
P 1 (1)
P 2 (1)

Trial Status

Withdrawn1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07282171Phase 1Recruiting

A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

NCT02782559Phase 2WithdrawnPrimary

Efficacy of Sildenafil in Preterm Preeclampsia

Showing all 2 trials

Research Network

Activity Timeline